Papers
Topics
Authors
Recent
Detailed Answer
Quick Answer
Concise responses based on abstracts only
Detailed Answer
Well-researched responses based on abstracts and relevant paper content.
Custom Instructions Pro
Preferences or requirements that you'd like Emergent Mind to consider when generating responses
Gemini 2.5 Flash
Gemini 2.5 Flash 72 tok/s
Gemini 2.5 Pro 57 tok/s Pro
GPT-5 Medium 43 tok/s Pro
GPT-5 High 23 tok/s Pro
GPT-4o 107 tok/s Pro
Kimi K2 219 tok/s Pro
GPT OSS 120B 465 tok/s Pro
Claude Sonnet 4 39 tok/s Pro
2000 character limit reached

DenseMP: Unsupervised Dense Pre-training for Few-shot Medical Image Segmentation (2307.09604v1)

Published 13 Jul 2023 in cs.CV

Abstract: Few-shot medical image semantic segmentation is of paramount importance in the domain of medical image analysis. However, existing methodologies grapple with the challenge of data scarcity during the training phase, leading to over-fitting. To mitigate this issue, we introduce a novel Unsupervised Dense Few-shot Medical Image Segmentation Model Training Pipeline (DenseMP) that capitalizes on unsupervised dense pre-training. DenseMP is composed of two distinct stages: (1) segmentation-aware dense contrastive pre-training, and (2) few-shot-aware superpixel guided dense pre-training. These stages collaboratively yield a pre-trained initial model specifically designed for few-shot medical image segmentation, which can subsequently be fine-tuned on the target dataset. Our proposed pipeline significantly enhances the performance of the widely recognized few-shot segmentation model, PA-Net, achieving state-of-the-art results on the Abd-CT and Abd-MRI datasets. Code will be released after acceptance.

List To Do Tasks Checklist Streamline Icon: https://streamlinehq.com

Collections

Sign up for free to add this paper to one or more collections.

Summary

We haven't generated a summary for this paper yet.

Dice Question Streamline Icon: https://streamlinehq.com

Follow-Up Questions

We haven't generated follow-up questions for this paper yet.